Management of Primary Choroidal Lymphoma Presenting As Extensive Serous Retinal Detachment and Salmon Patch of Bulbar Conjunctiva: A Case Report Publisher Pubmed



Mahdizad Z¹ ; Khalili Pour E¹ ; Mehrabi Bahar M¹ ; Esfandiari A¹ ; Masoomian B^{1, 2} ; Riaziesfahani H^{1, 2} ; Mirshahi A¹ ; Ghassemi F^{1, 2} Show Affiliations
Source: Journal of Medical Case Reports Published:2022

Abstract

Background: We describe the outcome of ultra-low-dose radiotherapy plus intravitreal methotrexate and rituximab injections for a patient with primary choroidal lymphoma who presented with nodular conjunctival salmon patches and extensive serous retinal detachment. Case presentation: A 34-year-old Iranian man presented with a nodular patch of bulbar conjunctiva in the right eye, and 1+ vitritis. A nearly complete shallow serous retinal detachment, retinal folds, and multifocal yellow choroidal infiltrates were seen during a fundus examination of the right eye. Enhanced depth imaging optical coherence tomography revealed macular retinal folds and an uneven, undulating, “seasick” appearance of the choroidal surface with choriocapillaris compression, intraretinal and subretinal fluid, and clusters of optically dense material at the outer retinal level. An incisional biopsy of the conjunctival lesion confirmed the diagnosis of primary choroidal lymphoma with epibulbar involvement. The patient was treated with ultra-low-dose “boom-boom” radiation (4 Gy delivered in two fractions over two consecutive days) as well as intravitreal methotrexate and rituximab injections. After a year, the lesions had completely disappeared, with no adverse effects or recurrence. Conclusion: Ultra-low-dose (boom-boom) radiotherapy combined with intravitreal chemotherapy and/or immunotherapy may be an effective treatment for primary choroidal lymphoma with anterior epibulbar extension and diffuse subretinal fluid with favorable response and minimal side effects. © 2022, The Author(s).